Insider Trading March 19, 2026

Hershey CFO Disposes of $325,065 in Shares Amid Strong Analyst Optimism

Steven Voskuil sold 1,500 Hershey shares under a Rule 10b5-1 plan as analysts raise targets following robust 2026 guidance

By Leila Farooq HSY
Hershey CFO Disposes of $325,065 in Shares Amid Strong Analyst Optimism
HSY

Hershey Chief Financial Officer Steven E. Voskuil sold 1,500 shares of HERSHEY CO (NYSE: HSY) on March 18, 2026, for $216.71 per share, generating proceeds of $325,065. The transaction occurred under an established Rule 10b5-1 plan. The stock has climbed 31% in the past year and analysts have responded to the company's strong 2026 EPS guidance with higher price targets.

Key Points

  • CFO Steven E. Voskuil sold 1,500 Hershey shares on March 18, 2026 under a Rule 10b5-1 plan, receiving $325,065.
  • Hershey stock has risen 31% in the past year; market cap reported at $42.8 billion and P/E at 48.53.
  • Analysts upgraded price targets and highlighted strong 2026 EPS guidance of 30-35% growth, citing potential benefits from lower cocoa costs and retail strength.

HERSHEY CO's Chief Financial Officer, Steven E. Voskuil, executed a sale of company stock on March 18, 2026, disposing of 1,500 shares at $216.71 per share for total proceeds of $325,065. The transaction was carried out pursuant to a Rule 10b5-1 trading plan that Voskuil adopted on May 20, 2025.

Following the disposition, Voskuil retains direct ownership of 59,869 Hershey shares. The sale comes as the confectionery maker's stock has risen approximately 31% over the prior 12 months, with the company's market capitalization noted at $42.8 billion and a reported price-to-earnings ratio of 48.53.

An InvestingPro analysis included in available coverage indicates that Hershey appears overvalued relative to its Fair Value, even as the company continues a long-running pattern of shareholder returns through dividends - having maintained dividend payments for 56 consecutive years.


Analyst reaction and outlook

Hershey's fourth-quarter report and optimistic 2026 earnings-per-share guidance - projecting 30-35% growth - drew several analyst responses that raised price targets or reiterated ratings.

  • Piper Sandler reiterated an Overweight rating and kept a $249.00 price target, highlighting the strong guidance and potential upside from favorable cocoa cost dynamics and retail results.
  • Stifel lifted its price target to $230.00 from $195.00 while maintaining a Hold rating, citing the company's improved outlook.
  • Bernstein SocGen Group increased its price target to $250.00 from $192.00, referencing 2026 guidance that exceeds consensus estimates.
  • DA Davidson raised its price target to $243.00 from $207.00, describing the company as on an accelerated path to earnings restoration.

Taken together, these analyst moves reflect generally constructive sentiment about Hershey's near-term earnings trajectory and the potential for cost tailwinds, particularly if cocoa prices remain favorable.


Context and limitations

The information here is limited to the disclosed insider transaction, summary valuation metrics and the cited analyst actions and guidance. No additional forecasts or external data beyond the stated items are introduced. The investing analysis referenced characterizes the stock as appearing overvalued relative to its Fair Value while also noting the company's long history of dividend payments.

Risks

  • Valuation risk - InvestingPro analysis indicates Hershey may be overvalued relative to its Fair Value, which could impact equity performance in the consumer staples and broader equities markets.
  • Commodity cost uncertainty - Future movements in cocoa prices could materially affect margins and earnings, affecting consumer packaged goods and retail sectors.
  • Sensitivity to guidance execution - The positive analyst responses are tied to 2026 EPS guidance; if Hershey fails to meet guidance, consumer and investor sentiment could be adversely affected.

More from Insider Trading

Alignment Healthcare CHRO Disposes $425k in Shares Across Two Transactions Mar 19, 2026 CytomX SVP Sells Shares to Cover RSU Taxes as Company Advances Clinical and Financing Plans Mar 19, 2026 Silver Lake Sells $36.7M in Dell Shares as Company Reports Strong AI Server Performance Mar 19, 2026 CytomX CFO Sells $124,111 in Stock as Company Advances Clinical Programs and Launches Large Offering Mar 19, 2026 Silver Lake Entities Liquidate $36.6M in Dell Class C Stock Amid Ongoing AI Momentum Mar 19, 2026